Crown (CCK) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
23 Mar, 2026Executive summary
The 2026 Annual Meeting will be held on April 30, 2026, in Tampa, Florida, with shareholders of record as of March 10, 2026, eligible to vote.
Four proposals are on the agenda: election of directors, ratification of independent auditors, advisory vote on executive compensation, and a shareholder proposal on written consent rights.
The Board recommends voting for all director nominees, for ratification of auditors, for executive compensation, and against the shareholder proposal.
Voting matters and shareholder proposals
Ten director nominees, all current board members, are up for election; nine are independent.
Proposal to ratify PricewaterhouseCoopers LLP as independent auditors for 2026.
Advisory vote on executive compensation (Say-on-Pay) is recommended for approval.
Shareholder proposal to allow action by written consent is opposed by the Board.
Board of directors and corporate governance
Board refreshment added six new independent directors in the last six years, enhancing diversity and skills.
Board practices include annual director elections, mandatory retirement, proxy access, and no poison pill.
All key committees are composed solely of independent directors; robust stock ownership guidelines are in place.
The Board’s Independent Lead Director has broad authority and leads executive sessions.
Latest events from Crown
- Q2 revenue and adjusted EPS up 16% year-over-year; full-year guidance raised on strong demand.CCK
Q2 202623 Jul 2026 - Record 2025 results, strong sustainability, and 2026 growth outlook with higher dividends.CCK
AGM presentation22 Jul 2026 - Record financial results, sustainability leadership, and strong 2026 growth outlook.CCK
AGM presentation22 Jul 2026 - Q3 2025 delivered higher adjusted EPS, strong European growth, and raised full-year guidance.CCK
Q3 20259 Jul 2026 - Q2 adjusted EPS up 19%, guidance raised, and robust share repurchases and cash flow outlook.CCK
Q2 20258 Jul 2026 - Record adjusted EBITDA, strong free cash flow, and robust shareholder returns highlight 2025 results.CCK
Q4 20258 Jul 2026 - Adjusted EPS up 11% and net sales up 13% on strong global beverage can demand and India expansion.CCK
Q1 20261 May 2026 - Strong global beverage can growth, higher earnings, and a $2B buyback program announced.CCK
Q2 20243 Feb 2026 - Strong beverage can growth and higher income offset by pension settlement charges.CCK
Q3 202419 Jan 2026